Vered Bisker-Leib - Nov 22, 2022 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: Chief Operating Officer
Signature: /s/ Vered Bisker-Leib
Stock symbol: CMPX
Transactions as of: Nov 22, 2022
Transactions value $: -$103,708
Form type: 4
Date filed: 11/25/2022, 03:41 PM
Previous filing: Nov 22, 2022
Next filing: Jan 23, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CMPX	Common Stock	Sale	-$62.6K	-14.9K	-1.38%	$4.19	1.07M	Nov 22, 2022	Direct	F1, F2
transaction	CMPX	Common Stock	Sale	-$41.1K	-9.57K	-0.89%	$4.30	1.06M	Nov 23, 2022	Direct	F1, F2
transaction	CMPX	Common Stock	Sale	-$9	-2	0%	$4.36	1.06M	Nov 25, 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are included in the Reporting Person's award agreement which allows the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.
F2	The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.30 per share on November 22, 2022 and $4.15 to $4.43 on November 23, 2022. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.

Content

The sales reported on this Form represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales are included in the Reporting Person's award agreement which allows the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction.

The price reported in Column 4 is the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $4.10 to $4.30 per share on November 22, 2022 and $4.15 to $4.43 on November 23, 2022. The reporting person hereby undertakes to provide, upon request, to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, full information regarding the number of shares purchased and prices within the range set forth above.